myasthenia gravis
0 sources
Summary
myasthenia gravis is a designated intractable/rare disease[1]. It ranks in the top 2% of designated intractable rare disease entities by monthly Wikipedia readership (21,941 views/month).[2]
Key Facts
- Instance of: class of disease[3]
- Subclass of: neuromuscular junction disease[4], autoimmune disease of musculoskeletal system[5], immune-mediated acquired neuromuscular junction disease[6], immune disorder[7], autoimmune disease of peripheral nervous system[8], disease[9]
- Commons category: Myasthenia gravis[10]
- Topic's main category: Category:Myasthenia gravis[11]
- Prevalence: 0.00015[12]
- External data available at URL: http://www.nanbyou.or.jp/entry/120[13]
- Described by source: Great Soviet Encyclopedia (1926–1947)[14]
- ICD-9-CM: 358.00[15], 358.0[16]
- NCI Thesaurus ID: C60989[17]
- Health specialty: neurology[18]
- Drug or therapy used for treatment: pyridostigmine[19], neostigmine[20], cyclosporine[21], (RS)-cyclophosphamide[22], prednisone[23], azathioprine[24], rituximab[25], eculizumab[26], mycophenolate mofetil[27], prednisolone[28], tacrolimus[29], distigmine[30], efgartigimod alfa[31]
- Genetic association: TNIP1[32], CTLA4[33]
- Exact match: http://purl.obolibrary.org/obo/DOID_437[34], http://identifiers.org/doid/DOID:437[35], http://www.orpha.net/ORDO/Orphanet_589[36]
Why It Matters
myasthenia gravis has Wikipedia articles in 29 language editions, a strong signal of global cultural recognition.[37] It is known by 36 alternative names across languages and contexts.[38]